ScholarIQanswers from OpenAlex

CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis

PaperCitations, authors & open-access status

CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis have?

ScholarIQcitation count

CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis has 31 citations in the OpenAlex counts ScholarIQ stores.

When was CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis published?

ScholarIQyear

CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis has 2018 year in the ScholarIQ index.

What is the open-access status of CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis?

ScholarIQoa status

CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis has bronze oa status in the ScholarIQ index.

What is the DOI of CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis?

ScholarIQdoi

The DOI for CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis is on the source record.

What is the PMID of CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis?

ScholarIQpmid

The PMID for CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis is on the source record.

What is the OpenAlex record for CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis?

ScholarIQopenalex

The OpenAlex for CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial